Correlation Between Eupraxia Pharmaceuticals and Kiromic Biopharma
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Kiromic Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Kiromic Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals Common and Kiromic Biopharma, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Kiromic Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Kiromic Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Kiromic Biopharma.
Diversification Opportunities for Eupraxia Pharmaceuticals and Kiromic Biopharma
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Eupraxia and Kiromic is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals Commo and Kiromic Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiromic Biopharma and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals Common are associated (or correlated) with Kiromic Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiromic Biopharma has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Kiromic Biopharma go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Kiromic Biopharma
If you would invest 268.00 in Kiromic Biopharma on November 2, 2024 and sell it today you would earn a total of 0.00 from holding Kiromic Biopharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 5.26% |
| Values | Daily Returns |
Eupraxia Pharmaceuticals Commo vs. Kiromic Biopharma
Performance |
| Timeline |
| Eupraxia Pharmaceuticals |
| Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Eupraxia Pharmaceuticals and Kiromic Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eupraxia Pharmaceuticals and Kiromic Biopharma
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Kiromic Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Kiromic Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiromic Biopharma will offset losses from the drop in Kiromic Biopharma's long position.| Eupraxia Pharmaceuticals vs. Biglari Holdings | Eupraxia Pharmaceuticals vs. Guangdong Investment Limited | Eupraxia Pharmaceuticals vs. Dennys Corp | Eupraxia Pharmaceuticals vs. Shenzhen Investment Holdings |
| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |